Polymer-based Prefilled Syringe Market: Overview
The need for convenience, minimal errors in clinical medication, and knowledge of prescribed dose, market for the polymer-based prefilled syringe is taken into attention. The more sensitive drugs enter the market, so the need for high quality and reliable packaging is increasing. The polymer-based prefilled syringe is cost-effective, safe, and provide accurate dose to be administered while setting a quality standard. Polymer-based prefilled syringe provide flexibility, more tolerance power, is break resistant and are brought up in the market in attractive designs. They have impact resistance properties and excellent transparency. Polymer-based prefilled syringe maintain consistent glide force, lower the probability for drug degradation, provide higher material strength and barrier properties. Polymer-based prefilled syringe play a vital role in various therapies by proving sterile and contamination free product. The polymer-based prefilled syringe is inert, which decreases the chances of chemical interaction with sensitive drugs. This factor can avoid the loss of integrity of medicines and avoid the chance of drug overfill by the consumers. In developing countries, therapies are being self-administered, which demanded to design innovative installing solutions that match the needs of the consumers. The polymer-based prefilled syringe is efficient enough in providing the required medication.
Download sample copy of this report:
Polymer-based Prefilled Syringe Market: Dynamics
The ability to provide a repeatable and predictable performance of drugs, the market for the polymer-based prefilled syringe is expected to rise. The need for change in the treatment area, from hospital to home care was important to treat chronic diseases. The shift in patients care with the progress of biopharmaceutical drug products has fueled the growth of polymer-based prefilled syringe market worldwide. Glass prefilled syringes are breakable when mishandled and can open doors for leaching of heavy metals which can add on to the growth of polymer-based prefilled syringe market. Though polymer-based prefilled syringe has a powerful impact on the area of healthcare yet, there are restraints which can suppress the growth of this market. They have relatively higher gas permeability than glass prefilled syringe which can allow atmospheric air into the syringe, so glass prefilled syringe is considered to be an excellent barrier. Glass is considered more dominant to polymer due to the need of improved health concerns. Despite the fact that glass prefilled syringe has more advantages over polymer-based prefilled syringe still the market of the polymer-based prefilled syringe is expected to grow because of the ease of handling and cost-effectiveness. The market for glass prefilled syringe is anticipated to have slow growth as compared to the polymer-based prefilled syringe market. Innovation in a polymer-based prefilled syringe for providing superior moisture-barrier can boost the net sales of this market.
Polymer-based Prefilled Syringe Market: Regional Outlook
Countries in the Europe, North America and the Asia Pacific has the highest consumption of medications and a huge market for pharmaceuticals, and therefore, the market for the polymer-based prefilled syringe is expected to rise. Polymer-based prefilled syringe market in developed countries such as the U.S., Italy, and the UK is expected to have positive growth during the forecast period. It attributed to the high demand for polymer-based prefilled syringe incorporated in the packaging of medicines. The increasing demand to reduce the medical error and increase the convenience, the market for polymer-based prefilled syringe in developing countries such as India, China, etc. are expected to rise.
Download Data Set @
Polymer-based Prefilled Syringe Market: Key Players
- Ajinomoto Bio-Pharma, Inc.
- Aptar Pharma (India) Pvt. Ltd.
- Baxter International Inc.
- Enable Injections, Inc.
- Nipro Corp.
- SHL Medical
- Shandong Weigao Group
- Stevanato Group
- Unilife Corporation